Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RIFAXIMIN for Colitis ulcerative: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 21 adverse event reports in the FDA FAERS database where RIFAXIMIN was used for Colitis ulcerative.

Most Reported Side Effects for RIFAXIMIN

Side Effect Reports % Deaths Hosp.
Death 3,687 26.6% 3,682 303
Hospitalisation 1,605 11.6% 198 1,602
Therapy interrupted 875 6.3% 162 563
Off label use 802 5.8% 46 115
Diarrhoea 709 5.1% 46 167
Ammonia increased 676 4.9% 90 564
Inability to afford medication 672 4.9% 89 396
Insurance issue 577 4.2% 88 336
Confusional state 530 3.8% 53 344
Hepatic cirrhosis 480 3.5% 305 224
Hepatic encephalopathy 462 3.3% 93 347
Product use in unapproved indication 439 3.2% 21 57
Drug ineffective 436 3.2% 68 148
Fall 433 3.1% 81 322
Product use issue 421 3.0% 91 258

Other Indications for RIFAXIMIN

Product used for unknown indication (6,357) Hepatic encephalopathy (2,587) Hepatic cirrhosis (1,346) Irritable bowel syndrome (964) Gastrointestinal bacterial overgrowth (626) Product use in unapproved indication (421) Liver disorder (384) Hepatic failure (361) Diarrhoea (210) Ammonia increased (156)

Other Drugs Used for Colitis ulcerative

ADALIMUMAB (34,530) VEDOLIZUMAB (33,987) INFLIXIMAB (21,373) INFLIXIMAB-DYYB (6,767) TOFACITINIB (6,358) MESALAMINE (6,347) UPADACITINIB (4,800) USTEKINUMAB (3,872) GOLIMUMAB (3,637) HUMIRA (2,707)

Related Pages

RIFAXIMIN Full Profile All Colitis ulcerative Drugs RIFAXIMIN Demographics RIFAXIMIN Timeline